Literature DB >> 16516475

Complexity of the TOR signaling network.

Ken Inoki1, Kun-Liang Guan.   

Abstract

The target of rapamycin (TOR) is a serine/threonine kinase of the phosphatidylinositol kinase-related kinase family and is highly conserved from yeast to mammals. TOR functions as a central regulator of cell growth and is itself regulated by a wide range of signals, including growth factors, nutrients and stress conditions. Recent studies in eukaryotic cells have identified two distinct TOR complexes, TORC1 and TORC2, which phosphorylate different substrates and have distinct physiological functions. Here, we discuss new findings that have extended the complexity of TOR signaling and the different roles of the TORC complexes in yeast, flies and mammals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516475     DOI: 10.1016/j.tcb.2006.02.002

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  76 in total

1.  Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice.

Authors:  Chong Chen; Yu Liu; Yang Liu; Pan Zheng
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

Review 2.  Organization of the ENaC-regulatory machinery.

Authors:  Rama Soundararajan; Ming Lu; David Pearce
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-04-16       Impact factor: 8.250

3.  PI3K-mTORC1 attenuates stress response by inhibiting cap-independent Hsp70 translation.

Authors:  Jun Sun; Crystal S Conn; Yan Han; Vincent Yeung; Shu-Bing Qian
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

Review 4.  Big roles for small GTPases in the control of directed cell movement.

Authors:  Pascale G Charest; Richard A Firtel
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

5.  mSIN1 protein mediates SGK1 protein interaction with mTORC2 protein complex and is required for selective activation of the epithelial sodium channel.

Authors:  Ming Lu; Jian Wang; Harlan E Ives; David Pearce
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

6.  Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish.

Authors:  Yonghe Ding; Xiaojing Sun; Wei Huang; Tiffany Hoage; Margaret Redfield; Sudhir Kushwaha; Sridhar Sivasubbu; Xueying Lin; Stephen Ekker; Xiaolei Xu
Journal:  Circ Res       Date:  2011-07-14       Impact factor: 17.367

7.  Krüppel-like factor 4 is induced by rapamycin and mediates the anti-proliferative effect of rapamycin in rat carotid arteries after balloon injury.

Authors:  Ying Wang; Beilei Zhao; Yi Zhang; Zhihui Tang; Qiang Shen; Youyi Zhang; Weizhen Zhang; Jie Du; Shu Chien; Nanping Wang
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 8.  Rapalogs in cancer prevention: anti-aging or anticancer?

Authors:  Mikhail V Blagosklonny
Journal:  Cancer Biol Ther       Date:  2012-11-14       Impact factor: 4.742

9.  Regulation of mTORC1 signaling by Src kinase activity is Akt1-independent in RSV-transformed cells.

Authors:  Martina Vojtechová; Jolana Turecková; Dana Kucerová; Eva Sloncová; Jirí Vachtenheim; Zdena Tuhácková
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

10.  New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.

Authors:  Gillian Libby; Louise A Donnelly; Peter T Donnan; Dario R Alessi; Andrew D Morris; Josie M M Evans
Journal:  Diabetes Care       Date:  2009-06-29       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.